January 16, 2026

New 3D imaging system could address limitations of MRI, CT and ultrasound

January 16, 2026 / Research update / InnovateMed Author / imaging system

Keck School of Medicine of USC researchers, working with a team of engineers from Caltech, developed an innovative medical imaging technique that maps both blood vessels and tissue. Peer-Reviewed Publication Keck School of Medicine of USC In a proof-of-concept study funded by the National Institutes of Health, researchers from the Keck School of Medicine of USC and […]

New 3D imaging system could address limitations of MRI, CT and ultrasound Read More »

Study finds so-called super agers tend to have at least two key genetic advantages

January 16, 2026 / Research update / InnovateMed Author / genetic advantage

A pair of Alzheimer’s risk genes were tracked in the largest study of super agers to date. Peer-Reviewed Publication Vanderbilt University Medical Center image: Leslie Gaynor, PhD, assistant professor of Medicine in the Division of Geriatric Medicine, who led the study with Alaina Durant, BS, statistical genetic analyst in the Vanderbilt Memory and Alzheimer’s Center. view more

Study finds so-called super agers tend to have at least two key genetic advantages Read More »

Sugar structures on kidney cells predict immune therapy response, study finds

January 16, 2026 / Immunology, Research update / InnovateMed Author / immune therapy response, kidney cells

by Inka Burow, Hannover Medical School edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Graphical abstract. Credit: Analytica Chimica Acta (2025). DOI: 10.1016/j.aca.2025.344724 Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These antibodies activate the immune system and enable T cells to detect and destroy

Sugar structures on kidney cells predict immune therapy response, study finds Read More »

Simple method can enable early detection and prevention of chronic kidney disease

January 16, 2026 / Research update / InnovateMed Author / CKD

by Karolinska Institutet edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Subtle abnormalities in kidney function—even within the range considered normal—may help identify people at risk of developing chronic kidney disease. This is shown in a new study from Karolinska Institutet, published in Kidney International. The researchers

Simple method can enable early detection and prevention of chronic kidney disease Read More »

FDA-cleared brain stimulation device for ADHD is not effective, new clinical trial finds

January 16, 2026 / Research update / InnovateMed Author / ADHD

by King’s College London edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Sleeping child with trigeminal nerve stimulation device. Credit: Astrid Perez A large multicenter clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD

FDA-cleared brain stimulation device for ADHD is not effective, new clinical trial finds Read More »

Scientists discover natural ‘brake’ that could stop harmful inflammation

January 16, 2026 / Research update / InnovateMed Author / inflammation

by University College London edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide. Inflammation is the

Scientists discover natural ‘brake’ that could stop harmful inflammation Read More »

Molecular ‘switch’ that turns on inflammation in obesity points to new therapeutic targets

January 16, 2026 / Research update / InnovateMed Author / obesity

by UT Southwestern Medical Center edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Obesity increased SAMHD1 phosphorylation and thereby compromised its deoxynucleoside triphosphatase function, ultimately leading to aberrant accumulation of cytosolic dNTPs in macrophages. Credit: Science (2026). DOI: 10.1126/science.adq9006. A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway

Molecular ‘switch’ that turns on inflammation in obesity points to new therapeutic targets Read More »

Ion channel offers promising avenue for new Parkinson’s drugs

January 16, 2026 / Research update / InnovateMed Author / parkinson drug

by Daniela Greulich, Hochschule Bonn-Rhein-Sieg edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Snapshots of TMEM175 in the open and closed state with H57 either protonated or deprotonated. Credit: Proceedings of the National Academy of Sciences (2026). DOI: 10.1073/pnas.2503909123 Lysosomes are the recycling centers of human cells. Larger molecules are broken

Ion channel offers promising avenue for new Parkinson’s drugs Read More »

Oral drug can safely lower triglycerides and other blood lipids, clinical trial finds

January 16, 2026 / Research update / InnovateMed Author / blood lipids

by Ecole Polytechnique Federale de Lausanne edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source A visual representation of the study. Credit: X. Li (EPFL) When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides. Triglycerides are a form of fat or lipid, which the

Oral drug can safely lower triglycerides and other blood lipids, clinical trial finds Read More »

Dupilumab Delivers Positive Results for Allergic Fungal Rhinosinusitis

January 16, 2026 / Research update / InnovateMed Author / allergic fungal rhinosinusitis

Treatment with dupilumab significantly improved outcomes for adults with allergic fungal rhinosinusitis (AFRS), based on new data presented at the American College of Allergy, Asthma, and Immunology (ACAAI) 2025 Annual Meeting. The new study focused specifically on AFRS, a type of chronic rhinosinusitis for which no previous treatment was approved, said lead investigator Amber U. Luong, MD, professor and vice

Dupilumab Delivers Positive Results for Allergic Fungal Rhinosinusitis Read More »